- Home
- IMNM vs TRIP Comparison
IMNM vs TRIP Comparison
Compare IMNM & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | TRIP |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | IMNM | TRIP |
|---|---|---|
| Price | $21.77 | $14.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 10 |
| Target Price | ★ $31.44 | $15.88 |
| AVG Volume (30 Days) | ★ 2.9M | 2.1M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.53 |
| EPS | N/A | ★ 0.59 |
| Revenue | $9,679,000.00 | ★ $1,891,000,000.00 |
| Revenue This Year | N/A | $5.18 |
| Revenue Next Year | $11.53 | $4.97 |
| P/E Ratio | ★ N/A | $24.04 |
| Revenue Growth | N/A | ★ 4.25 |
| 52 Week Low | $5.15 | $10.43 |
| 52 Week High | $25.30 | $20.16 |
Technical Indicators
Market Signals| Indicator | IMNM | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 41.13 |
| Support Level | $19.37 | $13.76 |
| Resistance Level | $22.57 | $14.34 |
| Average True Range (ATR) | 1.48 | 0.46 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 45.30 | 18.48 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2024, and TheFork, its dining brand, represented 10% of sales (about 8% of revenue were intersegment, which are eliminated from consolidated revenue).